Burgdorf - In the 2004/05 business year Ypsomed achieved new highs in terms of sales, profit and investments. The Ypsomed Group's consolidated sales rose 21.7% to CHF 241.8 million. In the core business (pen systems, pen needles and Ypsotec) sales even increased by 42.8%. Particularly pleasing was a 157.8% rise in operating profit to CHF 47.5 million, representing an operating profit margin of 19.7%. There was also a striking improvement in net profit, which rose 179.1% to CHF 39.2 million. This lead to a net profit per share of CHF 3.49 in the first year since the IPO, of which CHF 0.90 will be distributed to shareholders in the form of a repayment of nominal value. In the last 12 months Ypsomed invested CHF 71.5 million in the expansion of its production facilities and created over 130 new jobs. For the 2005/06 financial year Ypsomed is expecting sales to grow between 20% and 25% and the EBIT margin to increase slightly over 20%.
Press Releases Ypsomed Group